US Stock MarketDetailed Quotes
COCP Cocrystal Pharma
- 1.7600
- +0.0100+0.57%
Close Nov 12 16:00 ET
17.91MMarket Cap-1005P/E (TTM)
1.8000High1.7400Low11.68KVolume1.7700Open1.7500Pre Close20.62KTurnover0.17%Turnover RatioLossP/E (Static)10.17MShares3.100052wk High1.03P/B12.34MFloat Cap1.325052wk Low--Dividend TTM7.01MShs Float77.4000Historical High--Div YieldTTM3.43%Amplitude1.3250Historical Low1.7650Avg Price1Lot Size
About Cocrystal Pharma Company
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded in 2008 and is headquartered in Bothell, WA.
Company Profile
SymbolCOCP
Company NameCocrystal Pharma
Listing DateMar 12, 2018
Founded2014
CEODr. Gary L. Wilcox
MarketNASDAQ
Employees12
Fiscal Year Ends12-31
Address19805 North Creek Parkway
CityBothell
ProvinceWashington
CountryUnited States of America
Zip Code98011
Phone1-305-425-1780
Company Executives
- Name
- Position
- Salary
- Dr. Sam Lee, PhD
- President and Co-Chief Executive Officer
- 627.20K
- James J. Martin
- Co-Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer
- 627.20K
- Dr. Roger D. Kornberg, PhD
- Chairman of the Board
- 184.84K
- Fred Hassan
- Independent Director
- 49.47K
- Dr. Anthony Japour, M.D.
- Independent Director
- 79.97K
- Richard C. Pfenniger, Jr
- Independent Director
- 44.23K
- Dr. Phillip Frost, M.D.
- Independent Director
- 84.12K
- Steven D. Rubin
- Independent Director
- 113.51K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data